International Journal of Radiation Oncology * Biology * Physics
Volume 61, Issue 4 , Pages 1107-1116, 15 March 2005

Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience

  • Anne W.M. Lee, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China
    • Corresponding Author InformationReprint requests to: Anne W. M. Lee, F.R.C.R., Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong Kong, China. Tel: (+852) 25954173; Fax: (+852) 29045216
  • ,
  • W.M. Sze, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China
  • ,
  • Joseph S.K. Au, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China
  • ,
  • S.F. Leung, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, China
  • ,
  • T.W. Leung, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, China
  • ,
  • Daniel T.T. Chua, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China
  • ,
  • Benny C.Y. Zee, Ph.D.

      Affiliations

    • Department of Clinical Oncology, Comprehensive Cancer Trials Unit, Chinese University of Hong Kong, Hong Kong, China
  • ,
  • Stephen C.K. Law, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China
  • ,
  • Peter M.L. Teo, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, China
  • ,
  • Stewart Y. Tung, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, China
  • ,
  • Dora L.W. Kwong, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China
  • ,
  • W.H. Lau, F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China

Received 31 March 2004; received in revised form 12 July 2004; accepted 13 July 2004.

Purpose

To analyze the treatment results achievable for nasopharyngeal carcinoma in the modern era to identify the key failures for future improvement and to provide an updated baseline for future trials.

Methods and materials

The results of 2687 consecutive patients treated at all public oncology centers in Hong Kong during 1996–2000 were retrospectively analyzed. The stage distribution (by American Joint Committee on Cancer and International Union Against Cancer staging system, 1997) was 7% Stage I, 41% Stage II, 25% Stage III, and 28% Stage IVA–B. All patients were irradiated with 6-MV photons and the median total dose was 66 Gy. Only 23% of patients had additional treatment with chemotherapy.

Results

The 5-year local, nodal, and distant failure-free rates were 85%, 94%, and 81%, respectively; patients with local failure had significantly higher risk of nodal and distant failures. The 5-year progression-free, overall, and cancer-specific survival rates were 63%, 75%, and 80%, respectively. The presenting stage was the most important prognostic factor for all endpoints: with overall survival decreasing from 90% for Stage I to 58% for Stage IVA–B. The results achieved by the 2070 patients treated by radiotherapy alone were almost identical to that of the whole series, the distant failure-free rate among patients with locoregional control was 89% for Stage I–II and 75% for Stage III–IVB. The 860 patients (32%) staged with magnetic resonance imaging achieved significantly better results than those staged by computed tomography, the overall survival being 93% vs. 83% for Stages I–II, and 72% vs. 63% for Stages III–IVB (p = 0.001).

Conclusions

Treatment results for nasopharyngeal carcinoma have substantially improved in the modern era; future trials should be based on updated baseline results. Further reduction of distant failure is important for future breakthrough, particularly for patients with advanced disease.

Keywords:  Nasopharyngeal carcinoma , Survival , Pattern of failure

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0360-3016(04)02098-X

doi:10.1016/j.ijrobp.2004.07.702

International Journal of Radiation Oncology * Biology * Physics
Volume 61, Issue 4 , Pages 1107-1116, 15 March 2005